Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective

With the success of several clinical trials of products based on human serum albumin (HSA) and the rapid development of nanotechnology, HSA-based nanodrug delivery systems (HBNDSs) have received extensive attention in the field of nanomedicine. However, there is still a lack of comprehensive reviews...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Changyong, Zhang, Dagui, Pan, Yujing, Chen, Biaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459149/
https://www.ncbi.nlm.nih.gov/pubmed/37631411
http://dx.doi.org/10.3390/polym15163354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459149/
https://www.ncbi.nlm.nih.gov/pubmed/37631411
http://dx.doi.org/10.3390/polym15163354

Ejemplares similares